Fig. 7.

Mean (95% CI) changes in biomechanical parameters of hip subregions. ABL = abaloparatide; ALN = alendronate; BR = buckling ratio; CI = confidence interval; CSMI = cross‐sectional moment of inertia; PBO = placebo; Z = section modulus. For ABL/ALN versus BL, all p < 0.0001 except lower shaft CSMI at 6 months (p < 0.05), lower shaft Z at 6 months (p = not significant), and lower shaft BR at 6 months (p = not significant); for ABL/ALN versus PBO/ALN, all p < 0.05 except lower shaft at 6 months (p = not significant). n = 202 for PBO/ALN and n = 204 for ABL/ALN.